COG AAML1031: A Phase III Randomized Trial for Patients with de novo AML using Bortezomib and Sorafenib (IND#114480; NSC# 681239, NSC# 724772) for Patients with High Allelic Ratio FLT3/ITD [Serum Biomarkers for the Prediction of GVHD in Children]

  • Hijiya, Nobuko (PD/PI)

Project: Research project

Project Details

Effective start/end date6/12/1412/31/16


  • Children’s Hospital of Philadelphia
  • Hyundai Hope On Wheels